Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy

Blood-based biomarkers reflect systemic inflammation status and have prognostic and predictive value in solid malignancies. As a recently defined biomarker, Pan-Immune-Inflammation-Value (PIV) integrates different peripheral blood cell subpopulations. This retrospective study of collected data aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Şahin, Ahmet Bilgehan, Cubukcu, Erdem, Ocak, Birol, Deligonul, Adem, Oyucu Orhan, Sibel, Tolunay, Sahsine, Gokgoz, Mustafa Sehsuvar, Cetintas, Sibel, Yarbas, Gorkem, Senol, Kazım, Goktug, Mehmet Refik, Yanasma, Zeki Burak, Hasanzade, Ulviyya, Evrensel, Turkkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289916/
https://www.ncbi.nlm.nih.gov/pubmed/34282214
http://dx.doi.org/10.1038/s41598-021-94184-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289916/
https://www.ncbi.nlm.nih.gov/pubmed/34282214
http://dx.doi.org/10.1038/s41598-021-94184-7

Ejemplares similares